Faeth Therapeutics
FTH
24.92
-1.97
-7.33%
Faeth Therapeutics
US · FTH
#3576 by market cap
Listed 2021
24.92
-1.97
-7.33%
Live - 5344 symbols - heartbeat 235s ago
· 2026-10-08 08:56
Pre-market
24.87
-0.20%
After-hours
24.92
0.00%
- Market cap
- 643.94M
- P/E (TTM)i
- -0.41
- P/Bi
- 3.72
- EPSi
- -16.72
- Div yieldi
- 0.00%
- 52W posi
- 50%
Reader sentiment
Are you bullish or bearish on FTH?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
BTIG Maintains Faeth Therapeutics(FTH.US) With Buy Rating, Maintains Target Price $55Market Newswire · 2026/9/14
-
Rating change
Citi Maintains Faeth Therapeutics(FTH.US) With Buy Rating, Maintains Target Price $55Market Newswire · 2026/7/17
-
Rating change
TD Cowen Initiates Faeth Therapeutics(FTH.US) With Buy RatingMarket Newswire · 2026/9/9
-
Rating change
H.C. Wainwright Initiates Faeth Therapeutics(FTH.US) With Buy Rating, Announces Target Price $60Market Newswire · 2026/6/22
-
Needham Initiates Faeth Therapeutics(FTH.US) With Buy Rating, Announces Target Price $56Market Newswire · 2026/8/21
-
Rating change
Oppenheimer Initiates Faeth Therapeutics(FTH.US) With Buy Rating, Announces Target Price $60Market Newswire · 2026/7/28
-
Rating change
Oppenheimer Maintains Faeth Therapeutics(FTH.US) With Buy Rating, Maintains Target Price $60Market Newswire · 2026/8/5
-
H.C. Wainwright Maintains Faeth Therapeutics(FTH.US) With Buy Rating, Maintains Target Price $60Market Newswire · 2026/9/22
-
Rating change
Citizens JMP Initiates Faeth Therapeutics(FTH.US) With Buy Rating, Announces Target Price $51Market Newswire · 2026/7/21
-
Rating change
Raymond James Initiates Faeth Therapeutics(FTH.US) With Buy Rating, Announces Target Price $56Market Newswire · 2026/7/31
-
Guggenheim Initiates Faeth Therapeutics(FTH.US) With Buy Rating, Announces Target Price $70Market Newswire · 2026/9/16
-
Rating change
Baird Initiates Faeth Therapeutics(FTH.US) With Buy Rating, Announces Target Price $57Market Newswire · 2026/6/26
-
Lucid Capital Initiates Faeth Therapeutics(FTH.US) With Buy Rating, Announces Target Price $59Market Newswire · 2026/9/14
-
Rating change
JonesTrading Initiates Faeth Therapeutics(FTH.US) With Buy Rating, Announces Target Price $55Market Newswire · 2026/8/4
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 08:56:25 · For reference only, not investment advice and not tailored to your situation.